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Objective To determine risk factors for poor birth outcome and their population attributable fractions.
Methods 1688 women who attended for antenatal care were recruited into a prospective study of the effectiveness of syphilis 
screening and treatment. All women were screened and treated for syphilis and other reproductive tract infections (RTIs) during 
pregnancy and followed to delivery to measure the incidence of stillbirth, intrauterine growth retardation (IUGR), low birth weight 
(LBW) and preterm live birth.
Findings At delivery, 2.7% of 1536 women experienced a stillbirth, 12% of live births were preterm and 8% were LBW. Stillbirth 
was independently associated with a past history of stillbirth, short maternal stature and anaemia. LBW was associated with short 
maternal stature, ethnicity, occupation, gravidity and maternal malaria whereas preterm birth was associated with occupation, age 
of sexual debut, untreated bacterial vaginosis and maternal malaria. IUGR was associated with gravidity, maternal malaria, short 
stature, and delivering a female infant. In the women who had been screened and treated for syphilis, in between 20 and 34% of 
women with each outcome was estimated to be attributable to malaria, and 63% of stillbirths were estimated as being attributable 
to maternal anaemia. Screening and treatment of RTIs was effective and no association was seen between treated RTIs and adverse 
pregnancy outcomes.
Conclusion Maternal malaria and anaemia continue to be significant causes of adverse pregnancy outcome in sub-Saharan Africa. 
Providing reproductive health services that include treatment of RTIs and prevention of malaria and maternal anaemia to reduce 
adverse birth outcomes remains a priority.
Bulletin of the World Health Organization 2007;85:9-18.
Voir page 16 le résumé en français. En la página 16 figura un resumen en español.
Introduction
Adverse birth outcomes such as low birth 
weight (LBW) and prematurity are ass
sociated with increased infant morbidity 
and mortality.1 Maternal risk factors that 
are likely to be particularly important in 
subsSaharan Africa include reproducs
tive tract infections (RTIs), malaria and 
human immunodeficiency virus (HIV) 
infection.2–5 The impact of these infecs
tions is likely to be high because they are 
so prevalent. Up to 50% of stillbirths, 
for example, have been attributed to uns
treated maternal syphilis.6,7 Other RTIs 
associated with adverse birth outcomes 
include bacterial vaginosis (BV), gonors
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rhoea, and Chlamydia trachomatis and 
Trichomonas vaginalis infections.8–12
A few studies have documented 
other maternal factors associated with 
adverse pregnancy outcomes in subs
Saharan Africa.13–20 However, there are 
few data on the examination of multiple 
determinants of birth outcome and the 
proportion of adverse birth events ats
tributable to these factors from the study 
region, partly because of a lack of simple, 
inexpensive diagnostic methods.
We conducted a study to determine 
the effectiveness of syphilis screening and 
treatment in preventing adverse pregs
nancy outcomes in women in Mwanza 
city, northswest United Republic of 
Tanzania.21 This study allowed the 
concomitant measurement of the ims
portance and impact of other maternal 
factors in this population.
Methods
Study design and participants
The study methods have been described 
in detail elsewhere.21 In summary, a 
prospective cohort of 1688 women ats
tending an antenatal clinic (ANC) was 
recruited from the main ANC in Mwans
za city from 1997 to 2000 to examine 
the effectiveness of antenatal screening 
and treatment of syphilis. Women were 
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screened at the ANC for syphilis by the 
rapid plasma reagin assay (RPR). RPRs
positive women were treated with a stat 
dose of benzathine penicillin G, 2.4 
MU, by intramuscular injection. Inclus
sion criteria for enrolment included 
informed consent, residence in Mwanza 
city for at least 1 month and a viable 
pregnancy confirmed by ultrasound. 
Exclusion criteria included more than 
one fetus or congenital fetal abnormality 
seen on ultrasound, maternal diabetes, 
hypertension or a history of vaginal 
bleeding in the current pregnancy. For 
each RPRspositive woman consecutively 
enrolled, the next two RPRsnegative 
eligible women were recruited. Women 
were interviewed about their sociodes
mographic characteristics, obstetric hiss
tory, RTI symptoms and recent antibis
otic treatment. On examination, vaginal 
and cervical specimens were collected. 
Women diagnosed with T. vaginalis 
and/or Candida albicans on vaginal wet 
preparations were offered immediate 
treatment. ANC attendees were pros
vided with iron and folate supplements 
and chloroquine 300smg base following 
the Tanzanian national guidelines at that 
time. At a followsup visit 2 weeks later, 
participants were treated for any RTIs 
identified in reference laboratory tests 
done following national guidelines. 
Syphilis testing was repeated at the STD 
reference laboratory in Mwanza. Women 
who were RPRsnegative following the 
initial ANC screening, but who were 
found to be RPRsreactive at the reference 
laboratory were treated with benzathine 
penicillin G, 2.4 MU, by intramuscular 
injection.
A second RTI screen and treatment 
and an ultrasound examination were 
offered to women recruited before 32 
weeks gestation. Free treatment was ofs
fered to the sexual partners of women 
with RTIs. Participants were followed to 
delivery. As soon as possible after admiss
sion, a 10sml venous blood sample and 
a fingersprick sample for a malaria thick 
film and haematocrit were collected. A 
placental blood smear and a 10 mm³ 
placental biopsy from the maternal plas
cental surface were taken after delivery. 
Data were collected on birth outcomes 
and signs of congenital syphilis. Stillbirth 
was defined as a fetal death after 22 
weeks gestation, intrauterine fetal death 
(IUFD) as fetal death at or before 22 
weeks gestation, LBW as birth weight 
less than 2500 g, prematurity as delivery 
before 37 weeks gestation and intrauters
ine growth retardation (IUGR) as an 
LBW infant born at or after 37 weeks 
gestation.14,22,23 Gestational age was 
estimated by ultrasound and date of the 
last menstrual period. To treat potential 
congenital infections, infants of RPRs
positive mothers were given benzathine 
penicillin G (0.5 mg/kg, intramuscular) 
as soon as possible after birth.
Laboratory analysis
Serum samples taken at the ANC were 
tested onssite using a qualitative RPR 
test. Serum samples from all the women 
recruited were tested at the reference 
laboratory by the same RPR test and by 
the Treponema Palliidum haemagglutis
nation assay (TPHA) and a fluorescent 
treponemal antibody assay if the results 
of the RPR test and TPHA were positive 
and negative, respectively.
Gramsstained vaginal smears were 
examined for candidiasis and also for 
BV using the Nugent method.24 As 
previously described, trichomoniasis was 
diagnosed using wet preparations and 
culture, Neisseria gonorrhoeae by culture 
and C. trachomatis by an enzyme immus
noassay antigen detection test to allow 
early treatment of infected women.21 
Firstsvoid urine samples (the first few 
mls of urine passed when voiding the 
bladder) were tested by the polymerase 
chain reaction (PCR) for C. trachomatis 
and N. gonorrhoeae. Anonymous tests
ing for human immunodeficiency virus 
(HIV) using screening (Vironostika 
HIV UnisForm II, Organon Teknika, 
Boxtel, the Netherlands) and confirmas
tory ELISA (Enzygnost® AntisHIV 1/2 
Plus, Behring, Marburg, Germany) was 
performed on stored maternal serum 
collected at delivery.
Anaemia at delivery was diagnosed 
by measuring the percentage packed 
cell volume (PCV). A PCV of 37% or 
more was considered normal, 33–36% 
was defined as mild anaemia, 24–32% 
as moderate anaemia and below 24% as 
severe anaemia.
Peripheral and placental blood 
smears were examined for asexual mas
laria parasites. Placental malaria, diags
nosed by examining placental biopsies, 
was classified as: uninfected (no parasites 
or pigment); active (parasites in inters
villous spaces); activeschronic (parasites 
in maternal erythrocytes and pigment 
in fibrin or cells within fibrin and/or 
chorionic villous syncytiotrophoblast 
or stroma); pastschronic (no parasites 
and pigment confined to fibrin or cells 
within fibrin).25
Statistical analysis
Data were entered in dBase IV (Ashtons
Tate, USA) and analysed in STATA8 
(STATA Corporation, Texas, USA). 
Univariate analysis was performed to 
compare sociodemographic and maters
nal factors in women who were followed 
to delivery with those lost to followsup, 
and between treated RPRspositive and 
RPRsnegative women. Comparison of 
proportions was done by the c² test and 
Fisher’s exact test. Means of normally 
distributed continuous variables were 
compared using the tstest.
Potential risk factors for stillbirth, 
LBW, IUGR and preterm birth were 
examined separately for women followed 
to delivery. These were not stratified by 
syphilis serostatus because it had previs
ously been demonstrated that there was 
no difference in birth outcome between 
women treated for serological syphilis 
and seronegative women.21 To examine 
potential risk factors for adverse pregs
nancy outcomes, crude and adjusted 
odds ratios (OR) were obtained using 
multiple logistic regression. Statistical 
significance was assessed using the likes
lihood ratio test. Factors significant at 
P < 0.1 on univariate analyses were ens
tered in a multivariate model. Factors 
which remained significant (P < 0.10) 
were included in the final model for 
each outcome, together with variables of 
a priori interest (i.e. age, gravidity and 
HIV status).
The proportion of outcomes in the 
population attributable to the exposure 
(population attributable fraction (PAF)) 
was estimated for malaria, anaemia and 
HIV at delivery using a modification of 
the methods outlined by Benichou and 
Gail.26 The adjusted PAF = p (R’–1)/R’ 
where p is the prevalence of exposure 
among cases in the total population 
and R’ is the adjusted relative risk (RR). 
Bootstrapping techniques were used to 
calculate the 95% confidence interval 
for the adjusted PAF. Sampling weights 
equal to the inverse of the sampling 
fraction were applied to both the RPRs
positive and RPRsnegative women to 
allow for the sampling strategy.
Results
Cohort recruitment and  
follow-up
Recruitment and followsup have been 
described elsewhere.21 In total, 1688 
women were recruited into the cohort: 
559 were diagnosed as RPRspositive 
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and 1127 RPRsnegative by reference 
laboratory testing. Two women had 
incomplete serology and were excluded 
from further analysis.
A third trimester screen for RTIs 
was performed on 1283 (76.1%) women. 
One hundred and fifty women (8.9%) 
were lost to followsup before delivery. 
Women lost presdelivery were younger 
than those followed up (mean age 
22.8 versus 23.8 years, P = 0.01), more 
likely to be primigravidae (41.3% 
versus 28.3%, P = 0.001) and not curs
rently married (24.7% versus 14.3%, 
P = 0.001). Of the 1536 women fols
lowed to delivery, 1205 (78.5%) delivs
ered in hospital and 331 delivered at 
home or elsewhere. Two women died 
after giving birth (0.1%), both as a res
sult of postpartum haemorrhage. Birth 
weight was recorded for 1260 (84.3%) 
of the 1494 infants born alive.
Baseline sociodemographic 
characteristics
Further analysis was restricted to the 
1536 women who were followed to des
livery. Sociodemographic and maternal 
factors according to ANC RPR status are 
shown in Table 1. The mean age of the 
women was 23.8 years and most (86%) 
were currently married. Only 17.5% 
attended for antenatal care before 20 
weeks gestation. The mean gestational 
age at recruitment was 25.4 weeks (stans
dard deviation (SD) 6.1; range 7.1–42.0 
weeks).
There was a high prevalence of RTIs 
at enrolment, especially BV (29.9%), 
T. vaginalis (20.5%) and C. albicans 
(29.6%). PCR testing showed that only 
2.2% of the women had gonorrhoea and 
7.4% had C. trachomatis.
Prevalence of HIV, malaria and 
anaemia at delivery
Of 1518 women who had an HIV result 
at delivery, 177 (11.7%) were HIV posis
tive. Of the 1152 women for whom the 
results of placental biopsy were available, 
451 (39.2%) had evidence of placental 
malaria (Table 1). Overall 113/1138 
(9.9%) women had maternal malaria 
(peripheral blood parasitaemia) at the 
time of delivery. Anaemia was observed 
in 772/1189 (64.9%) women for whom 
haematocrit results were available, and 
402 (33.8%) had moderate or severe 
anaemia.
There was a borderline association 
between HIV and maternal malaria at 
delivery (14.3% of HIVspositive women 
had malaria whereas 9.3% were HIVs
negative; P = 0.075). An association was 
noted between parasite density and HIV 
status: of 126 HIVspositive women for 
whom a white blood cell count (WBC) 
had been recorded, 6.4% had a parasite 
count of > 50/200 WBC at delivery 
compared to 1.9% of 1002 HIVsnegative 
women (P = 0.002). The geometric mean 
parasite density in women with malaria 
was 12.1/200 WBC in HIVsnegative 
women and 36.8/200 WBC in HIVs
positive women (P = 0.04).
There was no association between 
placental malaria and HIV status (41.4% 
of HIVspositive versus 38.8% HIVs
negative women; P = 0.56). However, 
5.6% of the 126 HIVspositive women 
had a parasite count in active placental 
malaria infection of > 50/200 WBC at 
delivery compared to 1.2% of 1009 
HIVsnegative women (P = 0.04) whereas 
the geometric mean parasite densities 
were 36.7/200 WBC and 11.4/200 
WBC, respectively (P = 0.01).
Risk factors for adverse 
pregnancy outcomes
In total 230 (18%) of women had an 
adverse birth outcome. Univariate and 
multivariate analyses of the association 
of sociodemographic and biological 
variables with adverse birth outcomes 
are shown in Table 2.
Stillbirth and intrauterine fetal 
death
Overall, 42/1536 (2.7%) women exs
perienced a stillbirth or IUFD. Two 
cases of IUFD diagnosed at 19 weeks 
gestation were combined with stillbirth 
for this analysis. On univariate analysis, 
stillbirth was strongly associated with 
a past history of stillbirth, occupation, 
being a smoker at recruitment, short 
stature, and maternal HIV infection and 
maternal anaemia at delivery.
On multivariate analysis, stillbirth 
was independently associated with 
short stature (odds ratio (OR): 2.64), a 
past history of stillbirth (OR: 7.50) and 
maternal anaemia (OR: 3.74). Although 
few women smoked, there was some 
evidence that those who did were at 
increased risk of stillbirth (OR: 8.51; 
95% confidence interval, 0.9–78.4). 
There was also a borderline association 
with being a primigravida and with 
placental malaria; the highest risk was 
seen in women with active placental 
malaria (OR = 7.74) compared with no 
placental malaria.
Premature birth
Twelve per cent of mothers who had live 
births gave birth preterm. On univariate 
analysis, prematurity was associated with 
younger age (test for trend P = 0.01), 
occupation, marital status, snuff use, gras
vidity, untreated BV during pregnancy, 
peripheral maternal malaria, active 
chronic placental malaria and maternal 
anaemia at delivery.
Independent risk factors for preterm 
birth were occupation, sexual debut after 
age 15 years, untreated BV during pregs
nancy (OR: 2.95) and maternal malaria 
(OR: 3.19). Women with HIV infection 
were not at a significantly increased risk 
of preterm birth (OR: 1.06).
Low birth weight
Overall, 8.2% of live births for whom 
birth weight was recorded were LBW. 
On univariate analysis, giving birth to 
an infant with LBW was associated with 
younger age, nonsSukuma ethnicity, 
occupation, never having been mars
ried, short stature, low gravidity, taking 
metronidazole during pregnancy, uns
treated BV during pregnancy, not having 
chlamydia during pregnancy, maternal 
malaria, active chronic placental mas
laria and maternal anaemia. Receiving 
penicillin at enrolment and testing RPRs
positive at enrolment were associated 
with a lower risk of LBW in the unis
variate analysis. These two variables were 
strongly associated since RPRspositive 
women were treated with penicillin.
Independent risk factors for LBW 
were nonsSukuma ethnicity, occupation 
(staying at home compared to having 
employment), short stature (OR: 1.80), 
being a primigravida (OR: 1.76), not 
having C. trachomatis infection and mas
ternal malaria (OR: 5.44).
Intrauterine growth retardation
Analyses of IUGR were based on the 
1117 women who had fullsterm live 
births. Of these, 4% were defined as 
having IUGR which was associated with 
younger age, nonsSukuma ethnicity, 
occupation, short stature, low gravidity, 
female sex of baby, maternal malaria and 
placental malaria.
Independent risk factors were ocs
cupation, short stature (OR: 1.94), bes
ing a primigravida (OR: 2.14), a female 
baby (OR: 2.11) and maternal malaria 
(OR: 2.83).
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Table 1. Characteristics of 1536 women recruited during pregnancy and seen at delivery by rapid plasma reagin assay (RPR) 
status at recruitment
Total % RPR+ % RPR– % P
Age group
13–19 years 303 19.7 97 19.3 206 19.9 0.57
20–24 years 634 41.3 204 40.6 430 41.6
25–29 years 378 24.6 134 26.7 244 23.6
> 30 years 221 14.4 67 13.4 154 14.9
Marital statusa 0.88
Married 1 316 85.7 430 85.7 886 85.8
Not married 129 8.4 41 8.2 88 8.5
Widowed/divorced/separated 90 5.9 31 6.2 59 5.7
Education
None 205 13.4 103 20.5 102 9.9 < 0.001
Primary 1 154 75.1 369 73.5 785 75.9
Secondary 175 11.4 29 5.8 146 14.1
Tribe
Sukuma 540 35.2 229 45.6 311 30.1 < 0.001
Other 996 64.8 273 54.4 723 69.9
Residence in Mwanza
< 1 year 280 18.2 105 20.9 175 16.9 0.06
> 1 year 1 256 81.8 397 79.1 859 83.1
Gravidity
1–2 828 53.9 251 50.0 577 55.8 0.05
3–5 566 36.9 207 41.2 359 34.7
> 6 142 9.2 44 8.8 98 9.5
Housing (building material)
Concrete 872 56.8 237 48.1 635 62.4 < 0.001
Mud/wood 639 41.6 256 51.9 383 37.6
Literate
Yes 1 229 80.0 358 71.3 871 84.2 < 0.001
No 307 20.0 144 28.7 163 15.8
No. of sexual partners in last year
1 1 375 89.5 431 85.9 944 91.3 0.001
> 2 161 10.5 71 14.1 90 8.7
Prevalence of RTI at recruitment
Candida albicansb 454 29.6 138 27.5 316 30.6 0.21
Trichomonas vaginalis 315 20.5 143 28.5 172 16.6 < 0.001
Bacterial vaginosis 459 29.9 158 31.5 301 29.1 0.34
Neisseria gonorrhoeae c 33 2.2 14 2.8 19 1.8 0.23
Chlamydia trachomatis c 114 7.4 43 8.6 71 6.9 0.24
Prevalence of maternal factors at delivery
HIVd 177 11.7 73 14.7 104 10.2 0.01
Placental malariae 451 39.2 174 48.3 277 35.0 < 0.001
Peripheral malariaf 113 9.9 32 9.1 81 10.3 0.51
Anaemiag 772 64.9 270 73.0 502 61.3 < 0.001
a  1 woman missing marital status.
b  2 missing results.
c  1 missing result.
d  18 missing results.
e  384 missing results.
f  369 missing, 29 indeterminate results.
g  357 missing results; sample taken before actual delivery.
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Table 2. Multivariate analyses of factors associated with adverse birth outcomes
Stillbirtha Prematurityb Low birth weightc Intrauterine growth 
retardationd
Age (years) P = 0.71 P = 1.00 P = 0.74 P = 0.57
< 20 1 1 1 1
20–24 1.56 (0.5–5.0) 0.98 (0.6–1.7) 0.72 (0.4–1.3) 0.62 (0.3–1.5)
25–29 1.56 (0.3–7.1) 0.99 (0.5–1.9) 0.80 (0.4–1.8) 0.92 (0.3–3.0)
> 30 0.79 (0.1–5.4) 1.06 (0.5–2.3) 0.76 (0.3–2.1) 1.19 (0.3–4.8)
Ethnicity P = 0.28 P = 0.91 P = 0.03 P = 0.10
Non-Sukuma 1 1 1 1
Sukuma 0.58 (0.2–1.6) 0.98 (0.7–1.5) 0.56 (0.3–1.0) 0.53 (0.2–1.1)
Occupation P = 0.71 P = 0.08 P = 0.007 P = 0.07
At home 1 1 1 1
Skilled 0 0.43 (0.2–1.0) 0.28 (0.1–0.) 0.19 (0.1–1.5)
Manual/farmer 1.22 (0.4–3.3) 0.84 (0.5–1.4) 0.45 (0.2–0.) 0.50 (0.2–1.4)
Age at sexual debut (years) P = 0.13 P = 0.01 P = 0.50 P = 0.79
< 15 1 1 1 1
16–17 1.81 (0.6–5.4) 2.17 (1.2–3.8) 1.33 (0.7–2.3) 0.80 (0.3–1.9)
18–30 0.64 (0.2–2.4) 1. (1.1–3.6) 1.00 (0.5–1.9) 1.06 (0.4–2.5)
Smoker P = 0.13 P = 0.90 P = 0.36
No 1 1 1 –
Yes 8.51 (0.9–78.4) 1.16 (0.1–9.5) 3.17 (0.4–28) –
Height P = 0.03 P = 0.31 P = 0.01 P = 0.05
> 156 cm 1 1 1 1
< 156 cm 2.64 (1.1–6.3) 1.22 (0.8–1.8) 1.80 (1.1–2.) 1.4 (1.1–3.8)
Gravidity P = 0.09 P = 0.76 P = 0.06 P = 0.08
Multigravida 1 1 1 1
Primigravida 2.62 (0.9–8.0) 0.92 (0.6–1.5) 1.76 (1.0–3.2) 2.14 (0.9–5.1)
Past stillbirth P = 0.003 P = 0.21 P = 0.66 P = 0.74
No 1 1 1 1
Yes 7.50 (2.3–24.3) 1.64 (0.8–3.4) 1.29 (0.4–3.9) 0.71 (0.1–5.6)
Sex of baby P = 0.56 P = 0.60 P = 0.39 P = 0.03
Male 1 1 1 1
Female 0.78 (0.3–1.8) 0.90 (0.6–1.3) 1.22 (0.8–1.9) 2.11 (1.1–4.2)
Chlamydia trachomatise P = 0.27 P = 0.43 P = 0.03
No 1 1 1 –
Yes – untreated 0.97 (0.1–7.9) 0.59 (0.2–2.0) 0.1 (0.1–1.5) –
Yes – treated 3.65 (1.1–12.0) 1.15 (0.5–2.6) 0.33 (0.1–1.2) –
Trichomonas vaginalise P = 0.12 P = 0.39 P = 0.66 P = 0.28
No 1 1 1 1
Yes – treated 2.32 (1.0–5.7) 1.27 (0.8–2.0) 1.11 (0.6–1.9) 0.61 (0.2–1.5)
Yes – untreated 5.57 (0.5–66.1) 2.38 (0.5–12.1) – –
Bacterial vaginosise P = 0.18 P = 0.04 P = 0.44 P = 0.79
No 1 1 1 1
Yes – treated 1.79 (0.8–4.2) 0.1 (0.6–1.4) 1.08 (0.7–1.8) 1.09 (0.6–2.2)
Yes – untreated – 2.5 (1.3–6.6) 2.02 (0.7–5.7)
HIVf P = 0.74 P = 0.84 P = 0.31 P = 0.49
No 1 1 1 1
Yes 1.24 (0.4–4.4) 1.06 (0.6–1.9) 1.47 (0.7–3.0) 1.45 (0.5–4.0)
Maternal malariaf P = 0.15 P < 0.001 P < 0.001 P = 0.03
No 1 1 1 1
Yes 2.30 (0.8–6.7) 3.1 (1.–5.2) 5.44 (3.1–.5) 2.83 (1.2–6.7)
Placental malariaf P = 0.09 P = 0.35 P = 0.16 P = 0.49
No 1 1 1 1
Past chronic 1.84 (0.6–5.2) 1.11 (0.7–1.8) 1.17 (0.6–2.1) 1.33 (0.6–3.0)
Active chronic 1.92 (0.5–6.9) 1.53 (0.7–3.2) 1.65 (0.7–3.8) 2.24 (0.7–7.3)
Active 7.74 (1.8–32.7) 0.61 (0.2–2.1) 0.38 (0.1–1.9) 0.76 (0.1–7.1)
14 Bulletin of the World Health Organization | January 2007, 85 (1)
Research
Adverse birth outcomes in Tanzania Deborah Watson-Jones et al. 
Stillbirtha Prematurityb Low birth weightc Intrauterine growth 
retardationd
Maternal anaemiaf P = 0.02 P = 0.11 P = 0.18 P = 0.93
No 1 1 1 1
Yes 3.74 (1.1–12.8) 1.40 (0.9–2.1) 1.42 (0.8–2.4) 1.03 (0.5–2.1)
Note: bold type indicates a statistically significant result.
a  Adjusted for age, height, gravidity, history of stillbirth, HIV at delivery and maternal anaemia. Based on 1166 women with complete data for these variables.
b  Adjusted for age, occupation, gravidity, bacterial vaginosis during pregnancy, HIV at delivery and maternal malaria. Based on 1102 women with complete data 
for these variables.
c  Adjusted for age, tribe, occupation, height, gravidity, Chlamydia trachomatis at recruitment, HIV at delivery and maternal malaria. Based on 1090 women with 
complete data for these variables.
d  Adjusted for age, tribe, occupation, height, gravidity, baby’s sex, maternal malaria and HIV at delivery. Based on 964 women with complete data for these 
variables.
e  At recruitment or follow-up during pregnancy.
f  On admission for delivery.
(Table 2, cont.)
Population attributable fractions
The proportions of adverse outcomes 
attributable to malaria, anaemia and 
HIV are shown in Table 3. The press
ence of malaria in pregnancy, either 
maternal or placental, was associated 
with statistically significant PAFs of 
34% for stillbirth, 20% for prematurity, 
28% for LBW and 22% for IUGR. For 
prematurity, LBW and IUGR, the main 
associations were with peripheral maters
nal malaria and active chronic placental 
malaria. In contrast, stillbirth appeared 
to be attributable to both peripheral 
and active or chronic placental malaria. 
A substantial proportion of stillbirths 
were attributable to maternal anaemia 
(PAF 63%). The proportion of adverse 
outcomes attributable to HIV was 5% 
or less for each outcome.
Discussion
There is a high incidence of adverse birth 
outcomes in northern United Republic 
of Tanzania, even in women who receive 
a package of reproductive health care 
as part of the antenatal services. Risk 
factors for adverse birth outcomes are 
multifactorial and only some of them 
are preventable or treatable.
Documented risk factors for stills
birth in subsSaharan Africa include low 
socioeconomic status, nulliparity, mas
ternal syphilis, LBW, mode of delivery, a 
previous late fetal or early neonatal death 
and malaria, as well as anaemia and short 
stature as observed in this study.7,13, 27 
However, in many African populations 
without access to screening, maternal 
syphilis will remain the most important 
preventable cause of stillbirth.7 Efforts to 
screen and treat for this infection must be 
a priority.28,29 Where syphilis screening 
and treatment is being implemented efs
fectively, as in this study where adverse 
birth outcomes attributable to syphilis 
were effectively prevented, anaemia and 
placental malaria infection remain as 
other potentially preventable causes of 
stillbirth.
The risk factors for LBW and 
IUGR in this study were similar to those 
described in a previous review which 
showed that ethnic group, nutrition, low 
weight prespregnancy, parity, young mas
ternal age, short stature and malaria were 
important determinants of growth in 
utero in developing countries.14 In cons
trast to research findings in Uganda,30 
our study did not find any significant 
association on multivariate analysis 
between metronidazole treatment and 
LBW or preterm birth.
Our study showed a strong assos
ciation between preterm birth and the 
potentially preventable factors of BV and 
maternal malaria. Other determinants 
for prematurity in developing countries 
are unclear except for prespregnancy 
weight, maternal age and socioeconomic 
status. Vitamin A deficiency, which was 
not measured in our study, may also ins
fluence premature births in subsSaharan 
Africa.17
The results of this study highs
light several key points. First, as in 
other studies in subsSaharan Africa, 
there was a high prevalence of RTIs in 
pregnancy.31,32 However, apart from 
untreated BV, these had no significant 
association with adverse pregnancy 
outcome. Untreated RTIs have been ass
sociated with all the adverse pregnancy 
outcomes documented in this study. 
Treating RTIs in pregnancy with a single 
dose of ceftriaxone in Nairobi has been 
shown to increase birth weight and 
reduce the incidence of postpartum ens
dometritis.33 A study of mass treatment 
of RTIs in pregnant women in Uganda 
reported an increase in birth weight, 
and a reduction in rates of preterm birth 
and neonatal death in the intervention 
arm.32 In our study, in which treatment 
of RTIs was provided at several points in 
pregnancy, RTIs were not independent 
risk factors for adverse birth outcomes. 
This emphasizes the importance of inters
vening against RTIs as a routine part of 
antenatal services because their impact 
on adverse outcomes can be prevented 
so effectively. This can be done through 
simple syndromic management at sevs
eral points during antenatal care, but 
the use of rapid screening tests for RTIs, 
once available, may be more effective 
because they will identify asymptomatic 
infections. Resscreening women later in 
pregnancy and efforts to treat contacts 
should also be intensified.
Second, in a population in which 
the impact of maternal syphilis in pregs
nancy has been prevented, and in which 
most pregnant women have been treated 
for RTIs at the ANC, malaria and 
anaemia become the most significant 
preventable causes of adverse birth outs
come. In this study, maternal malaria 
at delivery was a stronger independent 
risk factor for prematurity, LBW and 
IUGR than placental malaria, although 
active placental malaria infection was 
associated with stillbirth. In cases of 
maternal malaria, LBW can result from 
either IUGR or premature delivery.34,35 
Infection acquired close to the time of 
delivery results in preterm birth, whereas 
antenatal infection acquired earlier ins
creases the risk of IUGR.24
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Table 3. Population attributable fractionsa for the association of maternal and placental malaria, anaemia and HIV infection 
with adverse pregnancy outcomes
Adjusted 
prevalenceb
Stillbirth Prematurity Low birth  
weight (LBW)
Intrauterine 
growth 
retardation 
(IUGR)
Any adverse 
outcomec
Peripheral malaria 10.2% 13% (0–37%) 14% (6–22%) 25% (14–36%) 17% (5–28%) 15% (–22%)
Placental malaria
Past chronic 20.8% 10% (0–31%) 1% (0–11%) 2% (0–13%) 3% (0–10%) 3% (0–11%)
Active chronic 11.4% 9% (0–30%) 10% (0–25%) 14% (0–38%) 13% (0–28%) 11% (2–23%)
Active 3.8% 7% (0–18%) 0% (0–4%) 0% (0–2%) 0% (0–9%) 0% (0–5%)
Any malariad 37.9% 34% (1–68%) 20% (5–35%) 28% (10–46%) 22% (7–36%) 22% (8–35%)
Maternal anaemia 62.2% 63% (26–100%) 19% (0–45%) 22% (0–52%) 13% (0–34%) 23% (3–43%)
Maternal HIV 
infection
10.5% 4% (0–21%) 0% (0–9%) 5% (0–13%) 4% (0–12%) 3% (0–9%)
Note: bold type indicates a statistically significant result.
a  Calculated by bootstrapping the formula p(OR–1)/OR where p is the proportion of cases exposed in the target population, and the odds ratio (OR) is the 
adjusted OR in Table 3. Estimates are based on 1000 bootstrap samples.
b  Prevalence of exposure in the target population, adjusted for the weighted sample of rapid plasma reagin assay (RPR)-positive and negative women selected 
into the study.
c  Any pregnancy ending in a stillbirth or delivery of a preterm or a low-birth-weight infant or an infant with intrauterine growth retardation.
d  Evidence of placental and/or peripheral maternal malaria infection.
In contrast to other studies in subs 
Saharan Africa, this study did not show 
any independent risk of adverse pregs
nancy outcome associated with maternal 
HIV infection.36 However, an assos
ciation between HIV status and both 
peripheral and placental malaria and 
higher parasite densities in HIVsinfected 
individuals was seen in this study as well 
as in several previous studies.37–39 Paritys
specific immunity appears to be reduced 
in HIVspositive women; women of all 
parities have a higher relative risk for 
malaria if they are HIVspositive.27,37,39,40 
This in turn may lead to an even higher 
rate of adverse pregnancy outcomes, als
though we did not observe this, with the 
exception of a univariate effect of HIV 
on stillbirth. Any effect on pregnancy 
outcome may be partially mediated 
through the effect of HIV infection on 
malaria and/or anaemia. Malaria pros
phylaxis may not be effective in this 
situation because placental parasitaemia 
was more common in HIVspositive 
than in HIVsnegative pregnant women 
treated with sulfadoxine–pyrimethamine 
in Kenya.38 Similar findings have been 
reported from Malawi.40
In developing countries, maternal 
anaemia is usually the result of iron 
deficiency and/or malaria. Hookworm 
infection and poor diet are believed to be 
important causes of iron deficiency.41,42 
Iron supplementation during pregnancy 
is therefore generally recommended and 
has been shown to increase the haemos
globin level and PCV in the mother’s 
blood postsdelivery and to increase the 
mean birth weight of infants.43 Maternal 
anaemia was not prevented in our study 
and this may relate to poor adherence 
to treatment with iron supplements or 
failure to control malaria adequately 
because of chloroquine resistance.
Both malaria and HIV can affect 
pregnancy outcomes indirectly bes
cause they are risk factors for maternal 
anaemia.2,42,44,45 Malaria prophylaxis in 
pregnancy can reduce the incidence of 
thirdstrimester anaemia 38 and is geners
ally recommended as a part of prenatal 
care in malariasendemic areas.46 This has 
been effective in reducing the incidence 
of LBW infants, especially those born to 
primigravidae, and in reducing maternal 
anaemia.47–49 Trials of sulphadoxine– 
pyrimethamine have reduced placental 
malaria and may explain how chemos
prophylaxis increases birth weight 38,50 
Malaria prophylaxis has had little effect 
on the rate of other birth outcomes such 
as stillbirths or neonatal deaths.48 In 
our study, chloroquine was the recoms
mended chemoprophylactic but had 
limited effectiveness in preventing infecs
tion because chloroquine resistance is 
common.34 Efforts are now being made 
in many parts of subsSaharan Africa to 
change to more effective regimens.49 The 
potential impact of an effective intervens
tion will be significant at the population 
level because more than one third of 
LBW and stillbirth cases and nearly a 
quarter of IUGR cases were attributs
able to malaria. Given the relationship 
between malaria and HIV in pregnant 
women infected with both, it will be 
important to document the effectives
ness of antiretroviral therapy for HIV 
on pregnancy outcomes and on the 
prevalence and severity of malaria in 
pregnancy in subsSaharan Africa as 
programmes of antiretroviral therapy are 
implemented.  O
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Résumé
Issues défavorables de l’accouchement en Tanzanie - Influence et prévention des facteurs de risque 
maternels
Objectif Déterminer les facteurs de risque pour diverses issues 
défavorables de l’accouchement et les fractions attribuables en 
population de ces issues.
Méthodes 1688 femmes bénéficiant de soins anténataux ont été 
incluses dans une étude prospective visant à évaluer l’efficacité 
du dépistage de la syphilis et de son traitement. Pendant leur 
grossesse, ces femmes ont toutes été soumises à un dépistage 
de la syphilis et ont éventuellement été traitées contre cette 
maladie ou d’autres infections de l’appareil reproducteur. Elles 
ont également fait l’objet d’un suivi jusqu’à l’accouchement, en 
vue de mesurer l’incidence des mortinaissances, des retards de 
développement intra-utérins, des faibles poids à la naissance et 
des naissances avant terme.
Résultats Parmi les 1536 accouchements, 2,7 %  ont donné un 
enfant mort-né, 12 % un enfant prématuré vivant et 8 % un enfant 
de faible poids à la naissance. La mortinaissance était associée 
de manière indépendante aux facteurs suivants : antécédents 
d’accouchement d’un enfant mort-né, et faible stature ou anémie 
maternelles. Le faible poids à la naissance pouvait être associé 
à une petite stature de la mère, à son origine ethnique, à sa 
profession, au nombre de grossesses et à la présence du paludisme 
chez la mère, tandis que la naissance avant terme pouvait être 
mise en relation avec la profession, l’âge au début de l’activité 
sexuelle et la présence d’une vaginite bactérienne non traitée ou 
d’un paludisme chez la mère. Le retard de croissance intra-utérin 
pouvait être corrélé avec le nombre de grossesses, la présence 
d’un paludisme chez la mère, une faible stature maternelle et 
la mise au monde d’une fille. Parmi les femmes chez lesquelles 
on avait détecté et traité une syphilis, 20 à 24 % des issues 
défavorables de l’accouchement ont été considérées comme 
imputables au paludisme et 63 % des mortinaissances à une 
anémie maternelle. Le dépistage et le traitement des infections 
de l’appareil reproducteur se sont révélés efficaces et aucune 
association n’a été relevée entre ces infections et des issues 
défavorables de la grossesse.
Conclusion Le paludisme et l’anémie maternels restent des 
causes importantes d’issues défavorables de la grossesse en 
Afrique subsaharienne. L’apport de services de santé génésique 
comprenant le traitement des infections de l’appareil reproducteur 
et la prévention du paludisme et de l’anémie chez la mère 
demeure une priorité pour réduire les issues défavorables de 
l’accouchement.
Resumen
Desenlaces adversos del parto en la República Unida de Tanzanía: impacto y prevención de los factores 
de riesgo maternos
Objetivo Identificar los factores de riesgo de desenlace adverso 
del parto y sus fracciones poblacionales atribuibles.
Métodos En un estudio prospectivo sobre la eficacia de la 
detección y tratamiento de la sífilis se incluyeron 1688 mujeres 
que esperaban recibir atención prenatal. Todas ellas fueron 
sometidas a pruebas de detección y tratamiento de la sífilis y de 
otras infecciones del aparato reproductor durante el embarazo, y 
fueron observadas hasta el parto para determinar la incidencia 
de muerte fetal, retraso del crecimiento intrauterino, bajo peso al 
nacer y parto antes del término.
Resultados Entre las 1536 mujeres observadas hasta el parto 
hubo un 2,7% de muertes fetales, un 12% de nacidos vivos antes 
del término y un 8% de recién nacidos con bajo peso al nacer. La 
muerte fetal se asoció de forma independiente a los antecedentes 
de muerte fetal y a la anemia y la baja estatura de la madre. El bajo 
peso al nacer se asoció a la baja estatura de la madre, su etnia y 
ocupación, el número de embarazos anteriores y los antecedentes 
de paludismo, mientras que el parto antes del término se asoció 
con la ocupación, la edad de inicio de las relaciones sexuales, la 
vaginosis bacteriana no tratada y los antecedentes de paludismo. 
El retraso del crecimiento intrauterino se asoció con el número de 
embarazos anteriores, el paludismo, la baja estatura de la madre 
y el sexo femenino del recién nacido. En estas mujeres sometidas 
a pruebas de detección y tratamiento de la sífilis, entre un 20 y un 
34% de cada uno de los desenlaces adversos fueron atribuibles 
al paludismo, mientras que el 63% de las muertes fetales fueron 
atribuibles a la anemia materna. La detección y tratamiento de 
las infecciones del aparato reproductor fue eficaz y no se observó 
ninguna asociación entre las infecciones tratadas y los desenlaces 
adversos del embarazo.
Conclusión El paludismo y la anemia materna siguen siendo 
causas importantes de desenlace adverso del embarazo en el África 
subsahariana. La prestación de servicios de salud reproductiva que 
incluyan el tratamiento de las infecciones del aparato reproductor 
y la prevención de la malaria y la anemia materna siguen siendo 
prioritarias para reducir los desenlaces adversos del embarazo.
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صخلم
اهنم ةياقولاو ةيموملأا راطتخلاا لماوع رثأ :ةدحتلما اينازنت ةيروهمج في تادلاولل ةرئاضلا لئاصحلا
 اهئازجأو  تادلاولل  ةئيسلا  لئاصحلل  راطتخلاا  لماوع  لىع  فرعتلا  :فدهلا
.ناكسلل ةوزعلما
 1688  هتجلاعمو  يرهزلا  يرحت  ةيلاعفل  ةيقابتسا  ةسارد  تلمش  :ةقيرطلا
 ءاسنلا  عيمج يّرحت  مت  دقو  ،ةدلاولل  ةقباسلا  ةياعرلا  قفارم  تراز  ةضيرم
 للاخ  ةيباجنلإا  ةانقلل  ىوادعلا  نم  هيرغبو  يرهزلاب  ةباصلإل  نهتجلاعمو
 لخاد  يننجلا  توم(  صلاملإا  ثودح  لدعم  سايقل  ةدلاولا  ولتو  لمحلا
 ةدلاوو ،ةدلاولا  دنع  ديلولا  نزو صقنو ،محرلا  لخاد  ومنلا  رخأتو  ،)محرلا
.)لمحلا ماتم لبق( جّدخلا ءايحلأا
 %12 نىاع مايف ،صلاملإا نم ًلاماح 1538 ينب نم %2.7 نىاع :تادوجولما
 صلاملإا قفارت دقو .ةدلاولا دنع ديلولا نزو صقن نم %8و جادخلا نم نهنم
 نزو صقن قفارت مايف ،مدلا رقفو تاهملأا ةماق صرقو صلاملإل قباوس عم
 ةنهلماو )ام قرعل ءماتنلاا( ةينثلإابو تاهملأا ةماق صرقب ةدلاولا دنع ديلولا
 رمعلاو  ةنهلما  عم  جادِخلا  قفارتو  ،تاهملأا  ىدل  ايرلالماو  لومحلا  ددعتو
 ايرلالماو  ةََجلاعلما  يرغ  لبهلما  ضارمأو  ،ةيسنجلا  ةقلاعلل  ةسرمام  لوأ  دنع
 ىدل ايرلالماو لومحلا ددعتب محرلا لخاد ومنلا رخأت قفارتو .تاهملأا ىدل
 مت  تياوللا  ءاسنلا  ينب  نمو  .ىثنلأل  نهتدلاوو  نهيدل  ةماقلا  صرقو  تاهملأا
 نم  %34  لىإ  %20  نم  نأ  ردق  يرهزلاب  نهتباصلإ  نهتجلاعمو  نهحسم
 لىإ  نْيَزعُي  دق  نهنأ  ر َّدقي  لئاصحلا  عيمج نم  ةدحاو  نهيدل  تيلالا  ءاسنلا
 دقو .ايرلالما نع مجانلا مدلا رقف لىإ ىزعي صلاملإا نم %63 نأو ،ايرلالما
 ىوادعلا  ينب  قفارت  ظحلاي  لمو  ،ًلااعف  ةيباجنلإا  ةانقلل  ىوادعلا  يرحت  ناك
.لمحلل ةرئاضلا لئاصحلا ينبو ةيباجنلإا ةانقلا في ةيباهتللاا
 لئاصحلل ةماهلا تاببسلما نم تاهملأا ينب مدلا رقفو ايرلالما لازتلا :جاتنتسلاا
 يعدتسيو .ةيقيرفلأا ءارحصلا بونج في ةعقاولا نادلبلا في لمحلل ةرئاضلا
 ليبسلا ىودع ةجلاعم لمشت يتلاو ،ةيباجنلإا ةحصلا تامدخ ميدقت رملأا
 نم  دحلا  فدهب  ،تاهملأا  ىدل  مدلا  رقفو  ايرلالما  نم  ةياقولاو  بياجنلإا
.تايولولأا نم كلذ لك رابتعاو ،ةرئاضلا ةيدلاولا لئاصحلا
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